Movement Alert｜CARsgen Therapeutics-B Declines 5.02% in Regular Trading, Discounted Placement Dilution and Institutional Selling Continue to Pressure Shares

Market Focus06-01

On June 1, CARsgen Therapeutics-B declined 5.02% in regular trading, trading at HK$17.23/share, with trading volume of HK$52.98 million.

The decline was primarily driven by the ongoing dilutive impact of a recently completed discounted share placement and continued institutional selling. The company completed a top-up placement of 23.7 million shares at HK$19.84 per share on May 19, raising net proceeds of approximately HK$4.62 billion. Post-placement, total issued shares increased to approximately 595 million. Of the proceeds, 70% will fund global clinical development of innovative drugs, 15% for R&D and production facilities, and 15% for working capital.

Within the Biotechnology sector, performance remained divergent. Among peers, AKESO rose 2.71%, 3SBIO gained 0.54%, while INNOVENT BIO fell 2.52%, BEIGENE declined 2.66%, and SKB BIO dropped 3.16%, reflecting broader sector valuation pressure that further weighed on individual stocks.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1145516808?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-01 11:09","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1145516808","market":"us","top_or_hot":-1,"title":"Movement Alert｜CARsgen Therapeutics-B Declines 5.02% in Regular Trading, Discounted Placement Dilution and Institutional Selling Continue to Pressure Shares","media":"Market Focus","content":"<p><p>On June 1, CARsgen Therapeutics-B declined 5.02% in regular trading, trading at HK$17.23/share, with trading volume of HK$52.98 million.</p><p>The decline was primarily driven by the ongoing dilutive impact of a recently completed discounted share placement and continued institutional selling. The company completed a top-up placement of 23.7 million shares at HK$19.84 per share on May 19, raising net proceeds of approximately HK$4.62 billion. Post-placement, total issued shares increased to approximately 595 million. Of the proceeds, 70% will fund global clinical development of innovative drugs, 15% for R&D and production facilities, and 15% for working capital.</p><p>Within the Biotechnology sector, performance remained divergent. Among peers, AKESO rose 2.71%, 3SBIO gained 0.54%, while INNOVENT BIO fell 2.52%, BEIGENE declined 2.66%, and SKB BIO dropped 3.16%, reflecting broader sector valuation pressure that further weighed on individual stocks.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜CARsgen Therapeutics-B Declines 5.02% in Regular Trading, Discounted Placement Dilution and Institutional Selling Continue to Pressure Shares</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜CARsgen Therapeutics-B Declines 5.02% in Regular Trading, Discounted Placement Dilution and Institutional Selling Continue to Pressure Shares\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-06-01 11:09</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On June 1, CARsgen Therapeutics-B declined 5.02% in regular trading, trading at HK$17.23/share, with trading volume of HK$52.98 million.</p><p>The decline was primarily driven by the ongoing dilutive impact of a recently completed discounted share placement and continued institutional selling. The company completed a top-up placement of 23.7 million shares at HK$19.84 per share on May 19, raising net proceeds of approximately HK$4.62 billion. Post-placement, total issued shares increased to approximately 595 million. Of the proceeds, 70% will fund global clinical development of innovative drugs, 15% for R&D and production facilities, and 15% for working capital.</p><p>Within the Biotechnology sector, performance remained divergent. Among peers, AKESO rose 2.71%, 3SBIO gained 0.54%, while INNOVENT BIO fell 2.52%, BEIGENE declined 2.66%, and SKB BIO dropped 3.16%, reflecting broader sector valuation pressure that further weighed on individual stocks.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02171","symbol_name":"科济药业-B","start_time":0,"source_url":"","article_id":"1145516808","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1145516808","pubTimestamp":1780283362,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On June 1, CARsgen Therapeutics-B declined 5.02% in regular trading, trading at HK$17.23/share, with trading volume of HK$52.98 million.The decline was primarily driven by the ongoing dilutive impact...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02171":"科济药业-B"},"translate_title":"动向提示|科济生物-B在常规交易中下跌5.02%，折价配售摊薄和机构抛售继续给股价带来压力","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02171":1},"content_text":"On June 1, CARsgen Therapeutics-B declined 5.02% in regular trading, trading at HK$17.23/share, with trading volume of HK$52.98 million.The decline was primarily driven by the ongoing dilutive impact of a recently completed discounted share placement and continued institutional selling. The company completed a top-up placement of 23.7 million shares at HK$19.84 per share on May 19, raising net proceeds of approximately HK$4.62 billion. Post-placement, total issued shares increased to approximately 595 million. Of the proceeds, 70% will fund global clinical development of innovative drugs, 15% for R&D and production facilities, and 15% for working capital.Within the Biotechnology sector, performance remained divergent. Among peers, AKESO rose 2.71%, 3SBIO gained 0.54%, while INNOVENT BIO fell 2.52%, BEIGENE declined 2.66%, and SKB BIO dropped 3.16%, reflecting broader sector valuation pressure that further weighed on individual stocks.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"shareholding","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1145516808","isCrawlerRequest":true}